The Debrisoft monofilament debridement pad for use in acute or chronic wounds

The guidance review for MTG17 The Debrisoft monofilament debridement pad for use in acute or chronic wounds is now complete.

The review decision has now been signed off by the director of NICE’s Centre for Health Technology Evaluation. It is recommended to amend the Guidance.

The review decision is now published and can be found here